Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $8.87 trillion, total revenue of $4.58 trillion and a weighted average PE ratio of 44.56.
Market Cap
8.87T
Revenue
4.58T
Profits
199.05B
PE Ratio
44.56
Profit Margin
4.34%
Dividend Yield
0.39%
1055 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -2.16% | 1,855,323 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 610.83B | -1.56% | 5,919,157 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 432.69B | -1.25% | 2,915,280 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 386.05B | -0.93% | 3,768,390 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 298.58B | -2.53% | 5,755,200 | 65.77B |
| 6 | NVS | Novartis AG | 277.39B | -1.90% | 1,006,645 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 261.67B | -2.87% | 2,758,791 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 215.92B | -0.33% | 4,937,440 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 198.85B | 1.25% | 1,572,685 | 45.20B |
| 10 | AMGN | Amgen Inc. | 191.67B | -1.48% | 906,725 | 37.22B |
| 11 | GILD | Gilead Sciences, Inc. | 161.58B | -0.96% | 3,336,553 | 29.74B |
| 12 | ABT | Abbott Laboratories | 154.99B | -3.40% | 8,284,708 | 45.13B |
| 13 | DHR | Danaher Corporation | 141.05B | -0.43% | 3,161,738 | 24.78B |
| 14 | PFE | Pfizer Inc. | 138.18B | -0.96% | 24,170,425 | 63.32B |
| 15 | CVS | CVS Health Corporation | 135.39B | 0.20% | 5,022,665 | 405.62B |
| 16 | ISRG | Intuitive Surgical, Inc. | 134.32B | -6.84% | 4,876,779 | 10.58B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 121.02B | -0.71% | 740,313 | 12.22B |
| 18 | SYK | Stryker Corporation | 119.43B | -6.01% | 3,248,346 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 116.35B | -3.99% | 9,846,342 | 48.48B |
| 20 | SNY | Sanofi | 103.69B | -1.83% | 1,749,229 | 54.60B |
| 21 | GSK | GSK plc | 102.50B | -1.93% | 2,969,297 | 43.29B |
| 22 | MDT | Medtronic plc | 101.49B | -5.12% | 6,582,785 | 36.36B |
| 23 | MCK | McKesson Corporation | 93.99B | -1.16% | 500,613 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 93.45B | 1.22% | 1,449,311 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 80.80B | -6.78% | 3,763,247 | 76.39B |
| 26 | CI | The Cigna Group | 80.27B | -0.34% | 728,436 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 66.80B | -0.97% | 291,953 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 63.47B | -4.37% | 15,543,253 | 20.61B |
| 29 | COR | Cencora, Inc. | 58.79B | -1.30% | 825,335 | 328.68B |
| 30 | ARGX | argenx SE | 54.49B | -1.83% | 232,816 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 53.79B | -1.70% | 1,705,237 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 51.90B | -1.81% | 3,298,058 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 51.85B | -0.45% | 4,509,407 | 28.34B |
| 34 | MDLN | Medline Inc. | 50.71B | -4.88% | 5,566,242 | 29.14B |
| 35 | HUM | Humana Inc. | 48.86B | 0.25% | 638,900 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 42.66B | -4.14% | 592,825 | 4.45B |
| 37 | HLN | Haleon plc | 42.52B | -1.47% | 3,665,866 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 41.55B | -1.98% | 1,352,228 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 39.33B | 0.58% | 2,098,533 | - |
| 40 | NTRA | Natera, Inc. | 39.05B | -0.07% | 737,222 | 2.50B |
| 41 | A | Agilent Technologies, Inc. | 38.35B | 1.29% | 1,266,875 | 7.23B |
| 42 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.65B | -2.10% | 798,840 | 4.29B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 37.03B | -1.18% | 2,261,036 | 17.35B |
| 44 | WAT | Waters Corporation | 37.01B | 0.99% | 491,174 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.70B | 0.18% | 756,172 | 16.63B |
| 46 | ONC | BeOne Medicines AG | 34.10B | 0.91% | 372,179 | 5.74B |
| 47 | CNC | Centene Corporation | 33.88B | 0.48% | 1,932,009 | 178.33B |
| 48 | ALC | Alcon Inc. | 33.56B | -3.00% | 2,910,647 | 10.63B |
| 49 | RPRX | Royalty Pharma plc | 32.07B | -1.35% | 1,581,213 | 2.44B |
| 50 | VEEV | Veeva Systems Inc. | 31.46B | -1.59% | 1,296,418 | 3.32B |
| 51 | ZTS | Zoetis Inc. | 31.02B | -1.84% | 3,698,384 | 9.53B |
| 52 | ILMN | Illumina, Inc. | 28.96B | 0.70% | 1,368,401 | 4.39B |
| 53 | DXCM | DexCom, Inc. | 28.59B | -2.95% | 2,869,241 | 4.82B |
| 54 | BIIB | Biogen Inc. | 28.35B | -8.14% | 3,128,131 | 9.94B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 28.01B | -5.70% | 7,882,143 | 20.98B |
| 56 | RMD | ResMed Inc. | 27.90B | -2.57% | 1,290,862 | 5.54B |
| 57 | MRNA | Moderna, Inc. | 26.74B | 0.57% | 3,228,300 | 2.23B |
| 58 | MTD | Mettler-Toledo International Inc. | 26.58B | 1.20% | 94,405 | 4.09B |
| 59 | PHG | Koninklijke Philips N.V. | 26.15B | -4.61% | 1,313,320 | 20.34B |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.36B | -0.22% | 489,766 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.12B | 1.19% | 2,452,846 | 8.26M |
| 62 | INSM | Insmed Incorporated | 23.86B | 0.86% | 1,476,002 | 819.56M |
| 63 | INCY | Incyte Corporation | 22.96B | 0.60% | 721,361 | 5.36B |
| 64 | BNTX | BioNTech SE | 22.84B | 0.29% | 790,257 | 3.23B |
| 65 | DGX | Quest Diagnostics Incorporated | 22.79B | -0.69% | 615,954 | 11.28B |
| 66 | LH | Labcorp Holdings Inc. | 22.63B | -0.24% | 602,981 | 14.14B |
| 67 | UTHR | United Therapeutics Corporation | 22.35B | -1.67% | 263,108 | 3.17B |
| 68 | GH | Guardant Health, Inc. | 21.22B | 1.04% | 1,022,667 | 1.08B |
| 69 | STE | STERIS plc | 20.29B | -4.09% | 628,777 | 5.94B |
| 70 | VTRS | Viatris Inc. | 18.99B | -0.52% | 6,800,451 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.61B | -3.25% | 2,527,469 | 8.41B |
| 72 | GMAB | Genmab A/S | 17.48B | -0.07% | 1,457,917 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.29B | -1.21% | 771,984 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 16.54B | 0.40% | 356,146 | 998.25M |
| 75 | BBIO | BridgeBio Pharma, Inc. | 16.51B | 1.37% | 1,860,088 | 579.96M |
| 76 | THC | Tenet Healthcare Corporation | 15.81B | -5.76% | 2,609,763 | 21.46B |
| 77 | MEDP | Medpace Holdings, Inc. | 15.34B | 1.31% | 233,383 | 2.68B |
| 78 | DVA | DaVita Inc. | 14.94B | -1.24% | 466,386 | 13.84B |
| 79 | JAZZ | Jazz Pharmaceuticals plc | 14.93B | 0.27% | 538,556 | 4.44B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.47B | -0.27% | 1,146,951 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.02B | -0.48% | 914,635 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.35B | -4.04% | 1,364,892 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.21B | -1.49% | 493,688 | 8.26B |
| 84 | FMS | Fresenius Medical Care AG | 13.02B | -1.19% | 444,540 | 22.32B |
| 85 | ICLR | ICON Public Limited Company | 12.89B | 1.27% | 484,994 | 8.27B |
| 86 | ALGN | Align Technology, Inc. | 12.79B | -1.08% | 268,959 | 4.10B |
| 87 | ELAN | Elanco Animal Health Incorporated | 12.72B | 1.31% | 3,251,752 | 4.89B |
| 88 | SNN | Smith & Nephew plc | 12.58B | -4.07% | 1,671,558 | 6.16B |
| 89 | MOH | Molina Healthcare, Inc. | 12.56B | -0.71% | 822,267 | 43.10B |
| 90 | PEN | Penumbra, Inc. | 12.44B | -0.80% | 443,111 | 1.45B |
| 91 | RVTY | Revvity, Inc. | 12.42B | 0.17% | 694,694 | 2.90B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.39B | 1.23% | 188,594 | 1.13B |
| 93 | AXSM | Axsome Therapeutics, Inc. | 12.11B | 3.07% | 364,674 | 708.24M |
| 94 | SMMT | Summit Therapeutics Inc. | 11.98B | 0.88% | 2,246,552 | - |
| 95 | ABVX | ABIVAX Sociรฉtรฉ Anonyme | 11.80B | -0.70% | 724,466 | 5.67M |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.33B | -1.00% | 889,052 | 3.24B |
| 97 | BAX | Baxter International Inc. | 11.26B | -3.43% | 3,978,903 | 11.32B |
| 98 | CRL | Charles River Laboratories International, Inc. | 11.17B | 0.92% | 569,786 | 4.03B |
| 99 | CYTK | Cytokinetics, Incorporated | 11.13B | -0.33% | 1,043,114 | 105.82M |
| 100 | TECH | Bio-Techne Corporation | 11.10B | -0.15% | 2,487,256 | 1.21B |
| 101 | PODD | Insulet Corporation | 11.02B | -1.80% | 1,656,184 | 2.90B |
| 102 | EHC | Encompass Health Corporation | 10.80B | -1.02% | 1,000,723 | 6.07B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.80B | -0.58% | 2,121,134 | 3.58B |
| 104 | TEM | Tempus AI, Inc. | 10.54B | 4.99% | 2,706,049 | 1.36B |
| 105 | GMED | Globus Medical, Inc. | 10.26B | -5.22% | 2,509,902 | 3.10B |
| 106 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.13B | -2.98% | 1,223,640 | 622.01M |
| 107 | APGE | Apogee Therapeutics, Inc. | 10.04B | 0.11% | 865,531 | - |
| 108 | KRYS | Krystal Biotech, Inc. | 10.02B | -6.50% | 394,032 | 417.30M |
| 109 | HSIC | Henry Schein, Inc. | 9.90B | 1.26% | 1,081,432 | 13.38B |
| 110 | NUVL | Nuvalent, Inc. | 9.83B | 0.02% | 908,915 | - |
| 111 | CORT | Corcept Therapeutics Incorporated | 9.72B | 5.40% | 824,839 | 769.10M |
| 112 | ENSG | The Ensign Group, Inc. | 9.66B | -1.05% | 317,741 | 5.27B |
| 113 | OSCR | Oscar Health, Inc. | 9.35B | -1.80% | 2,816,402 | 13.30B |
| 114 | KYMR | Kymera Therapeutics, Inc. | 9.30B | 2.36% | 269,386 | 51.48M |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 9.12B | 3.96% | 190,231 | 7.46M |
| 116 | IONS | Ionis Pharmaceuticals, Inc. | 9.10B | -2.96% | 3,554,558 | 1.06B |
| 117 | BRKR | Bruker Corporation | 9.09B | 1.29% | 977,015 | 3.46B |
| 118 | GKOS | Glaukos Corporation | 8.98B | 0.12% | 348,944 | 551.35M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 8.90B | -1.41% | 1,123,914 | 1.51B |
| 120 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.05% | 4,298,652 | 18.07M |
| 121 | UHS | Universal Health Services, Inc. | 8.75B | -5.39% | 1,301,774 | 17.76B |
| 122 | SYRE | Spyre Therapeutics, Inc. | 8.69B | 5.44% | 1,855,252 | - |
| 123 | QGEN | Qiagen N.V. | 8.61B | 0.51% | 1,890,205 | 2.10B |
| 124 | ALKS | Alkermes plc | 8.59B | -0.66% | 1,174,699 | 1.56B |
| 125 | PTGX | Protagonist Therapeutics, Inc. | 8.44B | 1.04% | 368,979 | 74.06M |
| 126 | RGEN | Repligen Corporation | 8.30B | 1.57% | 396,226 | 763.34M |
| 127 | IBRX | ImmunityBio, Inc. | 8.24B | 1.03% | 6,027,086 | 140.98M |
| 128 | ATR | AptarGroup, Inc. | 8.17B | 2.52% | 439,181 | 3.87B |
| 129 | HIMS | Hims & Hers Health, Inc. | 8.13B | 2.18% | 6,618,748 | 2.37B |
| 130 | PCVX | Vaxcyte, Inc. | 8.12B | -1.41% | 518,715 | - |
| 131 | BIO | Bio-Rad Laboratories, Inc. | 8.00B | 0.42% | 138,770 | 2.59B |
| 132 | IMVT | Immunovant, Inc. | 7.96B | 0.18% | 503,645 | - |
| 133 | HQY | HealthEquity, Inc. | 7.91B | -1.14% | 661,111 | 1.34B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.79B | -0.15% | 1,252,796 | 700.35M |
| 135 | AVTR | Avantor, Inc. | 7.73B | 7.15% | 10,462,216 | 6.55B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.51B | 2.00% | 513,189 | 217.17M |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 7.39B | 1.75% | 559,638 | 569.61M |
| 138 | PACS | PACS Group, Inc. | 7.10B | 3.63% | 940,389 | 5.43B |
| 139 | HNGE | Hinge Health, Inc. | 6.91B | -0.79% | 1,065,953 | 646.34M |
| 140 | LQDA | Liquidia Corporation | 6.82B | 7.65% | 952,611 | 288.07M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.66B | -2.93% | 535,897 | 1.55B |
| 142 | COGT | Cogent Biosciences, Inc. | 6.57B | 2.67% | 1,601,937 | - |
| 143 | XENE | Xenon Pharmaceuticals Inc. | 6.51B | -0.59% | 808,855 | 7.50M |
| 144 | CHE | Chemed Corporation | 6.50B | -0.11% | 85,426 | 2.54B |
| 145 | PTCT | PTC Therapeutics, Inc. | 6.49B | -3.82% | 1,049,437 | 827.11M |
| 146 | SRRK | Scholar Rock Holding Corporation | 6.46B | -1.39% | 538,145 | - |
| 147 | CGON | CG Oncology, Inc. | 6.32B | -1.10% | 567,765 | 5.07M |
| 148 | DFTX | Definium Therapeutics, Inc. | 6.12B | 5.68% | 1,134,925 | - |
| 149 | GRFS | Grifols, S.A. | 6.10B | -2.36% | 401,254 | 8.58B |
| 150 | ERAS | Erasca, Inc. | 6.06B | 8.88% | 8,451,446 | - |
| 151 | LGND | Ligand Pharmaceuticals Incorporated | 5.98B | -2.40% | 514,566 | 274.48M |
| 152 | TXG | 10x Genomics, Inc. | 5.79B | 9.18% | 2,454,338 | 638.78M |
| 153 | BLTE | Belite Bio, Inc | 5.79B | 0.06% | 79,544 | - |
| 154 | TFX | Teleflex Incorporated | 5.76B | -4.66% | 284,030 | 2.13B |
| 155 | TWST | Twist Bioscience Corporation | 5.75B | 2.13% | 612,954 | 409.48M |
| 156 | BLLN | BillionToOne, Inc. | 5.73B | 1.07% | 425,554 | 354.54M |
| 157 | BLCO | Bausch + Lomb Corporation | 5.68B | -1.67% | 278,003 | 5.21B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.53B | 2.54% | 747,643 | 1.34M |
| 159 | CELC | Celcuity Inc. | 5.45B | 7.77% | 1,727,780 | - |
| 160 | STVN | Stevanato Group S.p.A. | 5.41B | 0.25% | 176,367 | 1.39B |
| 161 | AMRX | Amneal Pharmaceuticals, Inc. | 5.33B | -2.68% | 930,433 | 3.05B |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.31B | 1.42% | 545,882 | 536.20M |
| 163 | ORKA | Oruka Therapeutics, Inc. | 5.28B | 3.54% | 695,521 | - |
| 164 | SHC | Sotera Health Company | 5.08B | -1.98% | 2,698,703 | 1.19B |
| 165 | CRSP | CRISPR Therapeutics AG | 4.98B | -0.20% | 1,354,934 | 4.10M |
| 166 | LEGN | Legend Biotech Corporation | 4.98B | -0.12% | 1,037,933 | 1.14B |
| 167 | RDNT | RadNet, Inc. | 4.93B | -0.95% | 452,584 | 2.14B |
| 168 | INDV | Indivior Pharmaceuticals, Inc. | 4.90B | - | 490,647 | 1.29B |
| 169 | CAI | Caris Life Sciences, Inc. | 4.79B | -0.64% | 2,556,063 | 907.29M |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.78B | 1.89% | 448,208 | 754.05M |
| 171 | MANE | Veradermics, Incorporated | 4.64B | 0.73% | 448,656 | - |
| 172 | VCYT | Veracyte, Inc. | 4.52B | -1.41% | 642,335 | 541.74M |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.41B | -0.29% | 981,553 | - |
| 174 | ALHC | Alignment Healthcare, Inc. | 4.37B | 3.68% | 2,033,102 | 4.26B |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 4.36B | -0.08% | 853,999 | 1.10B |
| 176 | LIVN | LivaNova PLC | 4.35B | -4.63% | 637,679 | 1.43B |
| 177 | TNGX | Tango Therapeutics, Inc. | 4.28B | 4.41% | 1,460,669 | 56.99M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | -3.85% | 966,903 | - |
| 179 | WAY | Waystar Holding Corp. | 4.26B | -3.67% | 1,554,300 | 1.16B |
| 180 | NVST | Envista Holdings Corporation | 4.25B | -0.32% | 1,687,225 | 2.81B |
| 181 | MMSI | Merit Medical Systems, Inc. | 4.24B | -2.91% | 323,022 | 1.54B |
| 182 | MMED | MiniMed Group, Inc. | 4.23B | -6.52% | 808,337 | 3.10B |
| 183 | LFST | LifeStance Health Group, Inc. | 4.18B | -1.01% | 1,796,904 | 1.49B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.16B | 1.98% | 1,196,876 | 10.68M |
| 185 | DOCS | Doximity, Inc. | 3.99B | -2.20% | 1,669,326 | 644.86M |
| 186 | CON | Concentra Group Holdings Parent, Inc. | 3.95B | -1.59% | 672,614 | 2.23B |
| 187 | PBLS | Parabilis Medicines, Inc. | 3.95B | 4.59% | 412,154 | - |
| 188 | DYN | Dyne Therapeutics, Inc. | 3.93B | 0.66% | 1,692,184 | - |
| 189 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | 0.09% | 457,384 | 22.57M |
| 190 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.02% | 4,086,146 | 596.96M |
| 191 | ICUI | ICU Medical, Inc. | 3.83B | -2.70% | 275,933 | 2.16B |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.72B | 0.36% | 82,414 | 803.79M |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.69B | -5.49% | 449,153 | 787.85M |
| 194 | ELVN | Enliven Therapeutics, Inc. | 3.62B | 1.85% | 444,777 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.61B | -14.12% | 5,095,376 | - |
| 196 | GPCR | Structure Therapeutics Inc. | 3.60B | -1.94% | 446,049 | - |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.58B | 1.37% | 502,013 | 236.00M |
| 198 | OGN | Organon & Co. | 3.55B | - | 932,692 | 6.16B |
| 199 | PRVA | Privia Health Group, Inc. | 3.54B | 0.68% | 675,516 | 2.25B |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.49B | 1.47% | 804,911 | 225.27M |
| 201 | ALMS | Alumis Inc. | 3.48B | -2.88% | 785,199 | 8.40M |
| 202 | ADPT | Adaptive Biotechnologies Corporation | 3.42B | 1.67% | 1,048,460 | 295.41M |
| 203 | WRBY | Warby Parker Inc. | 3.39B | 0.91% | 1,628,832 | 890.57M |
| 204 | BKD | Brookdale Senior Living Inc. | 3.38B | -1.81% | 4,482,971 | 3.00B |
| 205 | HAE | Haemonetics Corporation | 3.37B | -3.56% | 420,153 | 1.33B |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.36B | -1.00% | 410,629 | 415.62M |
| 207 | OPCH | Option Care Health, Inc. | 3.35B | -1.54% | 827,333 | 5.67B |
| 208 | NHC | National HealthCare Corporation | 3.30B | 1.78% | 68,215 | 1.53B |
| 209 | ITGR | Integer Holdings Corporation | 3.16B | -3.29% | 287,338 | 1.86B |
| 210 | RARE | Ultragenyx Pharmaceutical Inc. | 3.14B | -3.67% | 718,860 | 670.00M |
| 211 | GRAL | GRAIL, Inc. | 3.13B | 1.67% | 253,522 | 156.12M |
| 212 | VERA | Vera Therapeutics, Inc. | 3.08B | 3.52% | 1,434,807 | - |
| 213 | BEAM | Beam Therapeutics Inc. | 3.08B | -0.26% | 1,618,817 | 164.01M |
| 214 | CLDX | Celldex Therapeutics, Inc. | 3.01B | -0.49% | 531,581 | 865.00K |
| 215 | ACHC | Acadia Healthcare Company, Inc. | 2.90B | 3.35% | 2,735,681 | 3.37B |
| 216 | IRON | Disc Medicine, Inc. | 2.87B | -1.11% | 221,984 | - |
| 217 | QURE | uniQure N.V. | 2.87B | 1.41% | 730,173 | 18.09M |
| 218 | RGC | Regencell Bioscience Holdings Limited | 2.80B | 11.88% | 416,739 | - |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.71B | -1.39% | 550,202 | 776.83M |
| 220 | KOD | Kodiak Sciences Inc. | 2.70B | 5.30% | 717,715 | - |
| 221 | MBX | MBX Biosciences, Inc. | 2.70B | -5.60% | 1,143,586 | - |
| 222 | SLS | SELLAS Life Sciences Group, Inc. | 2.63B | 6.10% | 5,270,110 | - |
| 223 | TMDX | TransMedics Group, Inc. | 2.58B | -1.54% | 535,110 | 635.89M |
| 224 | IMNM | Immunome, Inc. | 2.56B | -0.70% | 515,825 | 4.02M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.55B | -1.34% | 255,269 | 229.58M |
| 226 | XRAY | DENTSPLY SIRONA Inc. | 2.54B | -0.70% | 4,139,192 | 3.68B |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.54B | 8.32% | 2,080,253 | - |
| 228 | CLOV | Clover Health Investments, Corp. | 2.54B | 5.47% | 4,023,198 | 2.21B |
| 229 | PGNY | Progyny, Inc. | 2.53B | 1.06% | 748,058 | 1.29B |
| 230 | GRDN | Guardian Pharmacy Services, Inc. | 2.51B | -1.77% | 204,575 | 1.46B |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.48B | -1.61% | 1,961,021 | 885.72M |
| 232 | KLRA | Kailera Therapeutics, Inc. | 2.47B | -4.36% | 230,741 | - |
| 233 | TARS | Tarsus Pharmaceuticals, Inc. | 2.43B | -4.69% | 1,771,821 | 535.08M |
| 234 | ASTH | Astrana Health, Inc. | 2.43B | 2.85% | 426,667 | 3.53B |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.42B | -0.65% | 363,619 | - |
| 236 | PHVS | Pharvaris N.V. | 2.40B | -2.05% | 211,231 | - |
| 237 | NRIX | Nurix Therapeutics, Inc. | 2.39B | 1.28% | 830,834 | 36.77M |
| 238 | AGIO | Agios Pharmaceuticals, Inc. | 2.37B | -1.55% | 439,392 | 66.05M |
| 239 | VCEL | Vericel Corporation | 2.36B | -2.88% | 450,167 | 292.09M |
| 240 | NKTR | Nektar Therapeutics | 2.27B | -1.58% | 646,212 | 55.63M |
| 241 | LMAT | LeMaitre Vascular, Inc. | 2.25B | -1.72% | 179,305 | 256.28M |
| 242 | BHVN | Biohaven Ltd. | 2.25B | -1.45% | 1,050,210 | - |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.23B | -3.50% | 311,172 | 1.09B |
| 244 | HTFL | HeartFlow, Inc. | 2.20B | -2.68% | 1,385,081 | 191.42M |
| 245 | ZLAB | Zai Lab Limited | 2.18B | -1.33% | 371,469 | 453.28M |
| 246 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | 5.70% | 1,662,552 | 217.17M |
| 247 | PVLA | Palvella Therapeutics, Inc. | 2.14B | 2.18% | 187,142 | - |
| 248 | MESO | Mesoblast Limited | 2.14B | 3.21% | 232,584 | 65.38M |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.13B | -1.62% | 949,010 | 52.04M |
| 250 | NEOG | Neogen Corporation | 2.11B | 0.52% | 891,648 | 870.56M |
| 251 | VRDN | Viridian Therapeutics, Inc. | 2.11B | 0.53% | 746,966 | 70.92M |
| 252 | NBTX | Nanobiotix S.A. | 2.10B | 4.78% | 69,107 | 38.27M |
| 253 | OMCL | Omnicell, Inc. | 2.09B | -1.44% | 497,796 | 1.23B |
| 254 | ATAI | AtaiBeckley Inc. | 2.08B | 13.68% | 10,716,932 | 3.49M |
| 255 | ABCL | AbCellera Biologics Inc. | 2.07B | 3.76% | 3,663,489 | 79.21M |
| 256 | AXGN | Axogen, Inc. | 2.06B | -1.82% | 720,769 | 238.11M |
| 257 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | -0.12% | 556,324 | 298.30M |
| 258 | ADMA | ADMA Biologics, Inc. | 2.06B | -1.11% | 1,588,455 | 509.86M |
| 259 | NUVB | Nuvation Bio Inc. | 2.05B | 1.99% | 6,585,230 | 143.05M |
| 260 | AVAH | Aveanna Healthcare Holdings Inc. | 2.04B | -3.10% | 1,431,213 | 2.52B |
| 261 | BFLY | Butterfly Network, Inc. | 2.03B | -4.07% | 5,328,482 | 102.92M |
| 262 | COAG | Hemab Therapeutics Holdings, Inc. | 2.03B | 9.82% | 269,804 | - |
| 263 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.02B | 4.48% | 1,332,816 | -665.00K |
| 264 | HRMY | Harmony Biosciences Holdings, Inc. | 2.02B | -1.91% | 702,395 | 899.11M |
| 265 | AGL | agilon health, inc. | 2.00B | 3.58% | 310,248 | 5.82B |
| 266 | HCM | HUTCHMED (China) Limited | 1.99B | 0.49% | 19,391 | 548.51M |
| 267 | KARD | Kardigan, Inc. | 1.99B | -5.50% | 221,976 | - |
| 268 | GLUE | Monte Rosa Therapeutics, Inc. | 1.98B | 6.87% | 822,214 | 42.95M |
| 269 | RAPP | Rapport Therapeutics, Inc. | 1.98B | 2.08% | 324,412 | 20.00M |
| 270 | ADUS | Addus HomeCare Corporation | 1.98B | -0.45% | 131,061 | 1.45B |
| 271 | SION | Sionna Therapeutics, Inc. | 1.97B | -0.77% | 192,620 | - |
| 272 | SGRY | Surgery Partners, Inc. | 1.96B | -5.57% | 1,797,198 | 3.34B |
| 273 | TYRA | Tyra Biosciences, Inc. | 1.95B | 0.24% | 423,533 | - |
| 274 | LKFT | Lakefront Biotherapeutics NV | 1.94B | -1.11% | 154,415 | 1.20B |
| 275 | MD | Pediatrix Medical Group, Inc. | 1.94B | -7.65% | 895,896 | 1.93B |
| 276 | URGN | UroGen Pharma Ltd. | 1.91B | -0.72% | 379,088 | 140.49M |
| 277 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | -4.06% | 1,507,154 | 2.18B |
| 278 | DMRA | Damora Therapeutics, Inc. | 1.90B | 10.39% | 385,916 | - |
| 279 | ALMR | Alamar Biosciences, Inc. | 1.89B | -0.64% | 168,671 | 87.16M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.87B | -0.42% | 273,150 | 367.34M |
| 281 | NTLA | Intellia Therapeutics, Inc. | 1.87B | 2.69% | 3,224,309 | 66.09M |
| 282 | BCAX | Bicara Therapeutics Inc. | 1.86B | 0.78% | 220,226 | - |
| 283 | ANAB | AnaptysBio, Inc. | 1.86B | -9.86% | 489,297 | 232.39M |
| 284 | WGS | GeneDx Holdings Corp. | 1.86B | -1.83% | 786,623 | 442.68M |
| 285 | NEO | NeoGenomics, Inc. | 1.86B | 1.06% | 1,186,387 | 745.97M |
| 286 | PGEN | Precigen, Inc. | 1.83B | -0.58% | 2,214,125 | 31.60M |
| 287 | TSHA | Taysha Gene Therapies, Inc. | 1.83B | 6.13% | 3,285,577 | 7.47M |
| 288 | GHRS | GH Research PLC | 1.83B | 4.95% | 71,866 | - |
| 289 | GENB | Generate Biomedicines, Inc. | 1.82B | -0.63% | 291,131 | 30.30M |
| 290 | STOK | Stoke Therapeutics, Inc. | 1.82B | -1.05% | 319,607 | 32.08M |
| 291 | ZBIO | Zenas BioPharma, Inc. | 1.81B | 3.05% | 516,743 | 10.00M |
| 292 | UFPT | UFP Technologies, Inc. | 1.81B | -1.66% | 232,480 | 608.85M |
| 293 | NVCR | NovoCure Limited | 1.80B | -3.17% | 765,964 | 674.41M |
| 294 | CMPS | COMPASS Pathways plc | 1.80B | 1.40% | 2,451,551 | - |
| 295 | BHC | Bausch Health Companies Inc. | 1.78B | -1.75% | 1,446,259 | 10.53B |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | 1.36% | 23,049,082 | 66.41M |
| 297 | ZYME | Zymeworks Inc. | 1.77B | -1.08% | 246,860 | 81.26M |
| 298 | IOVA | Iovance Biotherapeutics, Inc. | 1.77B | -2.10% | 11,803,551 | 285.61M |
| 299 | PLSE | Pulse Biosciences, Inc. | 1.76B | -1.70% | 164,556 | 751.00K |
| 300 | ATRC | AtriCure, Inc. | 1.74B | -1.38% | 808,002 | 552.16M |
| 301 | TRLV | Trulieve Cannabis Corp. | 1.74B | -0.11% | 684,084 | 1.17B |
| 302 | MPLT | MapLight Therapeutics, Inc. | 1.73B | 4.21% | 218,417 | - |
| 303 | ABSI | Absci Corporation | 1.73B | -0.15% | 2,416,126 | 1.84M |
| 304 | AAPG | Ascentage Pharma Group International | 1.73B | -2.91% | 2,711 | 82.08M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.71B | 0.95% | 533,293 | 2.71B |
| 306 | ANIP | ANI Pharmaceuticals, Inc. | 1.71B | -0.80% | 174,934 | 923.71M |
| 307 | IMCR | Immunocore Holdings plc | 1.70B | 2.99% | 877,850 | 412.81M |
| 308 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.68B | 2.28% | 2,638,378 | 204.73M |
| 309 | TDOC | Teladoc Health, Inc. | 1.67B | -3.94% | 2,399,192 | 2.51B |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.66B | 2.57% | 324,047 | 20.00M |
| 311 | HCSG | Healthcare Services Group, Inc. | 1.65B | -0.17% | 299,582 | 1.85B |
| 312 | MLTX | MoonLake Immunotherapeutics | 1.62B | -3.87% | 749,307 | - |
| 313 | VIR | Vir Biotechnology, Inc. | 1.61B | -2.06% | 1,266,492 | 65.50M |
| 314 | INVA | Innoviva, Inc. | 1.60B | -2.16% | 581,330 | 420.69M |
| 315 | INNV | InnovAge Holding Corp. | 1.58B | 3.28% | 233,608 | 949.17M |
| 316 | PSNL | Personalis, Inc. | 1.58B | - | 3,079,557 | 64.52M |
| 317 | SEPN | Septerna, Inc. | 1.56B | 0.44% | 368,467 | 72.26M |
| 318 | HROW | Harrow, Inc. | 1.54B | -0.98% | 230,440 | 268.68M |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.52B | -3.18% | 207,700 | - |
| 320 | CDNA | CareDx, Inc. | 1.49B | 0.19% | 449,097 | 412.82M |
| 321 | SVRA | Savara Inc. | 1.44B | -0.96% | 1,267,639 | - |
| 322 | IART | Integra LifeSciences Holdings Corporation | 1.43B | -0.91% | 903,047 | 1.64B |
| 323 | XERS | Xeris Biopharma Holdings, Inc. | 1.43B | 1.35% | 882,063 | 314.85M |
| 324 | ENOV | Enovis Corporation | 1.43B | -5.56% | 607,904 | 2.28B |
| 325 | INSP | Inspire Medical Systems, Inc. | 1.42B | -4.23% | 428,915 | 915.25M |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.41B | -2.38% | 313,443 | 83.72M |
| 327 | ARDT | Ardent Health, Inc. | 1.41B | -2.38% | 509,971 | 6.43B |
| 328 | AKTS | Aktis Oncology, Inc. | 1.40B | -0.68% | 664,910 | 8.28M |
| 329 | BLFS | BioLife Solutions, Inc. | 1.40B | 1.89% | 324,995 | 101.66M |
| 330 | OMDA | Omada Health, Inc. | 1.39B | -0.38% | 443,137 | 283.30M |
| 331 | NVAX | Novavax, Inc. | 1.39B | -5.27% | 2,978,481 | 596.34M |
| 332 | ATEC | Alphatec Holdings, Inc. | 1.38B | -7.55% | 2,054,298 | 787.08M |
| 333 | PNTG | The Pennant Group, Inc. | 1.38B | -0.40% | 183,206 | 1.02B |
| 334 | PRGO | Perrigo Company plc | 1.38B | -2.16% | 1,836,557 | 4.18B |
| 335 | AHG | Akso Health Group | 1.37B | 8.11% | 2,296 | 14.84M |
| 336 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 0.96% | 268,656 | 1.30M |
| 337 | STAA | STAAR Surgical Company | 1.36B | -1.48% | 324,676 | 290.38M |
| 338 | AHCO | AdaptHealth Corp. | 1.36B | -0.87% | 613,490 | 3.29B |
| 339 | PAHC | Phibro Animal Health Corporation | 1.33B | -0.33% | 162,203 | 1.50B |
| 340 | IMTX | Immatics N.V. | 1.28B | 1.46% | 128,742 | 43.00M |
| 341 | ARDX | Ardelyx, Inc. | 1.28B | 0.49% | 1,898,504 | 427.68M |
| 342 | JBIO | Jade Biosciences, Inc. | 1.27B | 0.14% | 951,787 | - |
| 343 | CNMD | CONMED Corporation | 1.27B | -0.92% | 736,752 | 1.37B |
| 344 | AVLN | Avalyn Pharma Inc. | 1.26B | 1.76% | 135,683 | - |
| 345 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | 1.36% | 1,128,514 | - |
| 346 | AMN | AMN Healthcare Services, Inc. | 1.25B | -5.15% | 506,510 | 3.42B |
| 347 | NUTX | Nutex Health Inc. | 1.23B | -0.13% | 72,377 | 879.95M |
| 348 | TRAX | First Tracks Biotherapeutics, Inc. | 1.21B | -0.71% | 498,485 | - |
| 349 | SDGR | Schrรถdinger, Inc. | 1.21B | -1.22% | 567,297 | 254.91M |
| 350 | QDEL | QuidelOrtho Corporation | 1.20B | -1.23% | 431,716 | 2.66B |
| 351 | MNKD | MannKind Corporation | 1.20B | -3.84% | 3,703,359 | 360.78M |
| 352 | CAPR | Capricor Therapeutics, Inc. | 1.20B | 0.39% | 709,808 | 11.13M |
| 353 | IRMD | IRADIMED CORPORATION | 1.18B | -5.51% | 138,821 | 86.28M |
| 354 | ALVO | Alvotech | 1.18B | -2.22% | 440,881 | 562.04M |
| 355 | WVE | Wave Life Sciences Ltd. | 1.18B | 3.03% | 1,609,278 | 71.80M |
| 356 | AZTA | Azenta, Inc. | 1.17B | -2.19% | 675,287 | 596.48M |
| 357 | AVNS | Avanos Medical, Inc. | 1.17B | 0.10% | 228,429 | 715.90M |
| 358 | EYPT | EyePoint, Inc. | 1.15B | -3.57% | 825,916 | 7.61M |
| 359 | MGTX | MeiraGTx Holdings plc | 1.15B | 0.89% | 646,631 | 79.76M |
| 360 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | 0.34% | 195,325 | 796.33M |
| 361 | AORT | Artivion, Inc. | 1.12B | -3.58% | 263,892 | 458.69M |
| 362 | DRTS | Alpha Tau Medical Ltd. | 1.12B | 1.64% | 317,887 | - |
| 363 | XNCR | Xencor, Inc. | 1.11B | 0.13% | 382,989 | 97.36M |
| 364 | GMRS | GMR Solutions Inc. | 1.11B | -1.66% | 258,276 | 5.83B |
| 365 | PRCT | PROCEPT BioRobotics Corporation | 1.10B | -8.67% | 1,545,451 | 322.02M |
| 366 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | -0.22% | 468,972 | - |
| 367 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | 0.86% | 627,485 | - |
| 368 | SPTX | Seaport Therapeutics, Inc. | 1.09B | 1.00% | 84,606 | - |
| 369 | SANA | Sana Biotechnology, Inc. | 1.07B | -1.65% | 1,452,823 | - |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.07B | -1.87% | 156,515 | 787.69M |
| 371 | TNDM | Tandem Diabetes Care, Inc. | 1.07B | -4.28% | 1,576,480 | 1.03B |
| 372 | FBRX | Forte Biosciences, Inc. | 1.06B | -2.11% | 595,744 | - |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.05B | -1.79% | 330,497 | 1.03B |
| 374 | OLMA | Olema Pharmaceuticals, Inc. | 1.05B | 1.01% | 473,987 | - |
| 375 | CERT | Certara, Inc. | 1.04B | -1.69% | 1,626,859 | 419.75M |
| 376 | CRON | Cronos Group Inc. | 1.04B | 0.18% | 498,171 | 159.54M |
| 377 | ETON | Eton Pharmaceuticals, Inc. | 1.03B | 0.71% | 228,315 | 86.93M |
| 378 | GDRX | GoodRx Holdings, Inc. | 1.02B | -0.99% | 459,902 | 787.89M |
| 379 | BIOA | BioAge Labs, Inc. | 1.01B | 4.75% | 392,919 | 10.32M |
| 380 | IVA | Inventiva S.A. | 1.01B | 2.33% | 1,183,990 | 7.94M |
| 381 | VOR | Vor Biopharma Inc. | 1.00B | 2.83% | 703,843 | - |
| 382 | EVO | Evotec SE | 1.00B | -12.55% | 262,900 | 859.03M |
| 383 | KURA | Kura Oncology, Inc. | 996.94M | 2.93% | 1,178,579 | 71.64M |
| 384 | PCRX | Pacira BioSciences, Inc. | 986.06M | -1.88% | 248,246 | 734.86M |
| 385 | ANRO | Alto Neuroscience, Inc. | 972.10M | -1.18% | 454,892 | - |
| 386 | AVTX | Avalo Therapeutics, Inc. | 968.26M | -2.59% | 630,914 | 59.00K |
| 387 | GLAS | Glass House Brands Inc. | 968.16M | -0.26% | 137,267 | 177.68M |
| 388 | JANX | Janux Therapeutics, Inc. | 965.99M | -1.86% | 580,864 | 13.73M |
| 389 | BVS | Bioventus Inc. | 962.32M | -4.56% | 412,050 | 576.30M |
| 390 | DBVT | DBV Technologies S.A. | 959.63M | -0.50% | 229,728 | 5.74M |
| 391 | PHAR | Pharming Group N.V. | 950.15M | -1.74% | 3,772 | 369.49M |
| 392 | SLDB | Solid Biosciences Inc. | 946.10M | -1.13% | 622,760 | - |
| 393 | LXRX | Lexicon Pharmaceuticals, Inc. | 941.70M | -2.30% | 1,095,180 | 69.64M |
| 394 | OPK | OPKO Health, Inc. | 928.76M | - | 2,343,709 | 581.12M |
| 395 | LBRX | LB Pharmaceuticals Inc | 923.39M | -0.16% | 180,323 | - |
| 396 | ABUS | Arbutus Biopharma Corporation | 911.64M | -1.07% | 1,107,635 | 191.45M |
| 397 | ANNX | Annexon, Inc. | 906.87M | -1.69% | 1,936,320 | - |
| 398 | GERN | Geron Corporation | 888.51M | -2.46% | 10,265,430 | 196.12M |
| 399 | FTH | Faeth Therapeutics, Inc. | 887.05M | 3.15% | 228,725 | - |
| 400 | PHAT | Phathom Pharmaceuticals, Inc. | 886.44M | 2.24% | 907,249 | 204.89M |
| 401 | TBPH | Theravance Biopharma, Inc. | 877.45M | 0.18% | 372,690 | 109.78M |
| 402 | TALK | Talkspace, Inc. | 875.25M | -0.10% | 968,187 | 238.37M |
| 403 | AVR | Anteris Technologies Global Corp. | 869.27M | -4.59% | 626,315 | 1.85M |
| 404 | INMD | InMode Ltd. | 858.19M | -1.45% | 470,668 | 374.64M |
| 405 | DSGN | Design Therapeutics, Inc. | 858.16M | -0.83% | 505,949 | - |
| 406 | HSTM | HealthStream, Inc. | 830.88M | -0.97% | 75,955 | 311.78M |
| 407 | AMPH | Amphastar Pharmaceuticals, Inc. | 829.17M | -2.51% | 255,712 | 720.53M |
| 408 | REPL | Replimune Group, Inc. | 826.44M | -0.91% | 2,893,841 | - |
| 409 | ODTX | Odyssey Therapeutics, Inc. | 822.54M | -2.44% | 400,964 | 1.06M |
| 410 | CTMX | CytomX Therapeutics, Inc. | 794.62M | -1.35% | 2,606,976 | 35.54M |
| 411 | TENX | Tenax Therapeutics, Inc. | 788.86M | -3.38% | 979,298 | - |
| 412 | OCS | Oculis Holding AG | 784.44M | -1.22% | 256,855 | 1.40M |
| 413 | NGNE | Neurogene Inc. | 781.93M | 2.40% | 171,530 | 925.00K |
| 414 | ZVRA | Zevra Therapeutics, Inc. | 776.77M | -0.30% | 640,633 | 122.29M |
| 415 | AURA | Aura Biosciences, Inc. | 773.20M | 0.14% | 534,472 | - |
| 416 | RIGL | Rigel Pharmaceuticals, Inc. | 763.58M | -0.07% | 129,414 | 299.77M |
| 417 | IMMX | Immix Biopharma, Inc. | 761.38M | 1.66% | 936,822 | - |
| 418 | OMER | Omeros Corporation | 760.30M | 4.95% | 1,094,887 | 9.89M |
| 419 | CLYM | Climb Bio, Inc. | 757.84M | 0.19% | 651,385 | - |
| 420 | ACRS | Aclaris Therapeutics, Inc. | 756.98M | -1.45% | 604,580 | 8.37M |
| 421 | SPRY | ARS Pharmaceuticals, Inc. | 755.70M | -1.68% | 1,601,918 | 98.99M |
| 422 | BBNX | Beta Bionics, Inc. | 755.32M | - | 1,251,474 | 110.24M |
| 423 | SIBN | SI-BONE, Inc. | 751.28M | -5.10% | 498,272 | 206.22M |
| 424 | DRUG | Bright Minds Biosciences Inc. | 730.11M | -1.88% | 230,465 | - |
| 425 | CBLL | CeriBell, Inc. | 727.17M | -1.82% | 331,891 | 95.07M |
| 426 | CADL | Candel Therapeutics, Inc. | 726.84M | 2.90% | 1,218,195 | - |
| 427 | SLBT | SL Science Holding Limited | 723.27M | 3.35% | 53,583 | - |
| 428 | SSII | SS Innovations International, Inc. | 718.47M | -1.37% | 118,862 | 48.47M |
| 429 | GYRE | Gyre Therapeutics, Inc. | 714.09M | 1.03% | 65,949 | 117.05M |
| 430 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 712.15M | 4.34% | 335,894 | - |
| 431 | XOMA | XOMA Royalty Corporation | 710.16M | - | - | 48.56M |
| 432 | CSTL | Castle Biosciences, Inc. | 701.99M | 0.72% | 133,922 | 339.92M |
| 433 | EVH | Evolent Health, Inc. | 697.38M | 4.73% | 1,811,553 | 1.89B |
| 434 | MNPR | Monopar Therapeutics Inc. | 674.37M | -2.57% | 471,875 | - |
| 435 | SGP | SpyGlass Pharma, Inc. | 669.67M | 0.65% | 143,845 | - |
| 436 | PHR | Phreesia, Inc. | 664.17M | -2.58% | 390,070 | 495.59M |
| 437 | TECX | Tectonic Therapeutic, Inc. | 660.61M | 1.95% | 212,481 | - |
| 438 | IRWD | Ironwood Pharmaceuticals, Inc. | 658.45M | -4.99% | 1,713,591 | 361.51M |
| 439 | RLMD | Relmada Therapeutics, Inc. | 654.51M | -3.26% | 729,398 | - |
| 440 | CRMD | CorMedix Inc. | 650.37M | -0.36% | 566,087 | 400.05M |
| 441 | ACHV | Achieve Life Sciences, Inc. | 645.73M | 3.11% | 1,358,683 | - |
| 442 | ALLO | Allogene Therapeutics, Inc. | 640.26M | -3.89% | 4,189,928 | 22.00K |
| 443 | RGNX | REGENXBIO Inc. | 636.41M | -3.45% | 1,312,757 | 87.82M |
| 444 | TOI | The Oncology Institute, Inc. | 631.39M | 1.04% | 3,178,010 | 545.76M |
| 445 | PRME | Prime Medicine, Inc. | 627.65M | -1.14% | 2,948,942 | 4.03M |
| 446 | MDXG | MiMedx Group, Inc. | 626.32M | 3.06% | 1,092,415 | 389.42M |
| 447 | TCMD | Tactile Systems Technology, Inc. | 621.42M | -5.13% | 177,109 | 343.52M |
| 448 | CERS | Cerus Corporation | 614.13M | -0.81% | 1,659,257 | 216.56M |
| 449 | FDMT | 4D Molecular Therapeutics, Inc. | 613.20M | 3.81% | 490,576 | 88.24M |
| 450 | CTKB | Cytek Biosciences, Inc. | 597.28M | 2.55% | 787,385 | 204.17M |
| 451 | DNA | Ginkgo Bioworks Holdings, Inc. | 591.19M | - | 598,128 | 151.40M |
| 452 | AGMB | AgomAb Therapeutics NV | 590.48M | -2.60% | 44,760 | - |
| 453 | WEAV | Weave Communications, Inc. | 587.19M | 1.37% | 1,123,885 | 248.72M |
| 454 | BWAY | BrainsWay Ltd. | 582.31M | 2.52% | 59,026 | 56.22M |
| 455 | FLGT | Fulgent Genetics, Inc. | 579.66M | -0.05% | 164,878 | 320.35M |
| 456 | NVCT | Nuvectis Pharma, Inc. | 576.60M | -0.81% | 69,693 | - |
| 457 | MYGN | Myriad Genetics, Inc. | 571.41M | 3.24% | 606,687 | 829.00M |
| 458 | ALT | Altimmune, Inc. | 569.81M | -2.01% | 2,623,265 | 36.00K |
| 459 | EIKN | Eikon Therapeutics, Inc. | 553.30M | -2.11% | 218,900 | - |
| 460 | CTNM | Contineum Therapeutics, Inc. | 550.51M | 0.72% | 196,649 | - |
| 461 | NPCE | NeuroPace, Inc. | 547.89M | -6.13% | 78,919 | 99.53M |
| 462 | ANGO | AngioDynamics, Inc. | 538.95M | 1.21% | 1,474,010 | 320.17M |
| 463 | ARVN | Arvinas, Inc. | 532.95M | 1.98% | 480,845 | 89.40M |
| 464 | ASMB | Assembly Biosciences, Inc. | 531.89M | -0.45% | 72,316 | 71.10M |
| 465 | TLRY | Tilray Brands, Inc. | 521.86M | -1.91% | 3,104,920 | 858.28M |
| 466 | CBIO | Crescent Biopharma, Inc. | 507.41M | -2.68% | 41,353 | 11.88M |
| 467 | AQST | Aquestive Therapeutics, Inc. | 506.89M | -0.49% | 705,945 | 50.27M |
| 468 | RZLT | Rezolute, Inc. | 505.10M | 2.00% | 1,042,902 | - |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 470 | NRC | NRC Health | 495.81M | 0.78% | 73,533 | 138.64M |
| 471 | KIDS | OrthoPediatrics Corp. | 495.72M | -6.85% | 139,718 | 243.30M |
| 472 | VSTM | Verastem, Inc. | 490.33M | 3.91% | 2,514,702 | 49.59M |
| 473 | OCGN | Ocugen, Inc. | 489.16M | 2.48% | 3,868,168 | 4.47M |
| 474 | EDIT | Editas Medicine, Inc. | 486.47M | 0.32% | 1,534,381 | 38.69M |
| 475 | CTEV | Claritev Corporation | 482.62M | -5.13% | 209,113 | 978.76M |
| 476 | ZURA | Zura Bio Limited | 482.59M | -1.36% | 636,922 | - |
| 477 | KYTX | Kyverna Therapeutics, Inc. | 480.28M | 1.67% | 1,117,788 | - |
| 478 | STTK | Shattuck Labs, Inc. | 480.02M | -2.64% | 606,613 | 1.00M |
| 479 | CLPT | ClearPoint Neuro, Inc. | 479.83M | -3.09% | 440,085 | 40.61M |
| 480 | VALN | Valneva SE | 478.73M | -2.66% | 55,742 | 180.25M |
| 481 | SGMT | Sagimet Biosciences Inc. | 477.96M | 8.25% | 944,276 | - |
| 482 | SOPH | SOPHiA GENETICS SA | 476.53M | -0.70% | 98,567 | 81.18M |
| 483 | PROK | ProKidney Corp. | 471.21M | -3.11% | 1,574,245 | 889.00K |
| 484 | PACB | Pacific Biosciences of California, Inc. | 469.01M | 1.34% | 2,144,378 | 160.03M |
| 485 | VMD | Viemed Healthcare, Inc. | 459.66M | -2.76% | 277,642 | 286.57M |
| 486 | OVID | Ovid Therapeutics Inc. | 458.20M | 1.03% | 895,716 | 7.12M |
| 487 | SRTA | Strata Critical Medical, Inc. | 456.43M | 5.29% | 495,059 | 228.58M |
| 488 | ARTV | Artiva Biotherapeutics, Inc. | 455.27M | 4.93% | 372,293 | 251.00K |
| 489 | PRTA | Prothena Corporation plc | 454.95M | -1.59% | 376,972 | 57.94M |
| 490 | DCTH | Delcath Systems, Inc. | 452.92M | 1.94% | 234,301 | 90.44M |
| 491 | SLN | Silence Therapeutics plc | 452.03M | 3.01% | 274,352 | 839.00K |
| 492 | BNTC | Benitec Biopharma Inc. | 448.32M | 0.46% | 44,721 | - |
| 493 | VREX | Varex Imaging Corporation | 445.07M | -2.22% | 535,401 | 857.50M |
| 494 | SI | Shoulder Innovations, Inc. | 443.18M | -4.51% | 67,750 | 53.89M |
| 495 | OFIX | Orthofix Medical Inc. | 442.62M | -7.12% | 234,303 | 825.37M |
| 496 | PRLD | Prelude Therapeutics Incorporated | 437.37M | -0.68% | 259,963 | 16.72M |
| 497 | CABA | Cabaletta Bio, Inc. | 436.99M | -3.07% | 2,572,524 | - |
| 498 | STRO | Sutro Biopharma, Inc. | 433.65M | -6.00% | 149,531 | 99.61M |
| 499 | EVMN | Evommune, Inc. | 433.30M | -0.58% | 463,327 | 10.00M |
| 500 | CYH | Community Health Systems, Inc. | 432.77M | -8.19% | 2,772,608 | 12.29B |